TESAMORELIN 10mg

Description

Tesamorelin 10mg – Research Peptide

Tesamorelin 10mg is a high-purity, research-grade peptide supplied for controlled laboratory investigation involving peptide signaling pathways, neuroendocrine communication systems, and peptide-receptor interaction models.

Tesamorelin is a synthetic peptide analog of growth hormone-releasing hormone (GHRH) that has been referenced in scientific literature examining molecular signaling pathways within endocrine communication systems.

Within research environments, Tesamorelin peptides have been discussed in experimental contexts involving hypothalamic signaling pathways and pituitary peptide signaling mechanisms.

Tesamorelin 10mg is provided strictly for in-vitro laboratory research and analytical investigation. This material is not approved for human or veterinary use.

What Is Tesamorelin?

Tesamorelin is a synthetic peptide analog derived from growth hormone-releasing hormone (GHRH), a neuropeptide associated with signaling pathways between the hypothalamus and pituitary gland.

Scientific literature referencing Tesamorelin commonly discusses experimental models involving peptide signaling communication within endocrine regulatory systems.

This peptide has been examined within laboratory settings exploring molecular signaling interactions associated with neuroendocrine communication pathways.

Areas referenced in research literature include:

• Hypothalamic-pituitary signaling pathways
• Growth hormone-releasing hormone (GHRH) receptor interaction models
• Peptide-mediated endocrine signaling systems
• Neuroendocrine communication pathways
• Molecular signaling mechanisms involving regulatory peptides
• Hypothalamic-pituitary endocrine signaling pathways
• GHRH receptor interaction studies
• Molecular peptide signaling mechanisms
• Endocrine communication pathway modeling

These topics remain areas of ongoing scientific investigation.

Tesamorelin 10mg – Research Supply Specifications

• Synthetic research peptide
• 10mg lyophilized peptide per vial
• Analytical purity standard: 99%+
• Third-party laboratory testing for identity and purity
• Manufactured under controlled quality standards
• Canada-based fulfillment
• Batch-level quality verification

Purity & Quality Assurance

ExoLabz provides research peptides manufactured to high analytical standards. ExoLabz products undergo independent third-party testing to verify peptide identity and purity. Results are published on this site.

Researchers may conduct additional analytical verification if required for laboratory use. If validated testing confirms a verified purity discrepancy, ExoLabz provides refund and testing reimbursement in accordance with company policy.

Important Legal Notice

For Research Purposes Only

Tesamorelin 10mg is supplied strictly for laboratory research and analytical use.

This compound is not intended for human consumption, veterinary use, clinical research involving human subjects, therapeutic use, or diagnostic applications.

This product has not been evaluated or approved by Health Canada, the U.S. Food and Drug Administration (FDA), or any other regulatory authority.

By purchasing this product, the buyer confirms that the material will be handled only by qualified professionals and used solely for lawful laboratory research purposes.

Compound identity and specification

Identity data for Tesamorelin, published so the material can be checked against an independent record rather than taken on trust. The formula, mass and registry number below are verified against PubChem and can be looked up directly.

Analytical note — Tesamorelin. At 44 residues plus an N-terminal hexenoyl group this is the largest molecule in the catalogue, and the acyl group is the point: it is what distinguishes tesamorelin from unmodified GRF(1-44). On a 5,136 g/mol parent, single-residue deletions are a sub-1% mass shift, so purity here depends on chromatographic resolution more than on mass alone.

Identity references The molecular formula, molecular mass and CAS registry number above are taken from the PubChem record linked in the table, not from a supplier datasheet, so every figure can be checked against an independent source in one click. Sequences are given as reported in the peptide literature, in the one-letter or three-letter convention as appropriate, with any non-standard residue named in full. Where a compound exists in more than one form — a free peptide and a metal complex, a fragment and its parent protein, a modified and an unmodified analog — the form supplied is the one identified here, and the mass on the certificate of analysis is what distinguishes it.

Research Literature

Peer-reviewed studies involving this compound and its class. All findings listed are from in vitro, cell culture or animal models and are provided for scientific reference only. This product is supplied for laboratory research and is not approved for human consumption, clinical, or veterinary use.

• Ferdinandi ES, et al. Basic Clin Pharmacol Toxicol. 2007;100(1):49-58. In rats, dogs and pigs, measured enzymatic stability of the trans-3-hexenoyl modification, plasma elimination kinetics and plasma IGF-1 response. Source · PMID 17214611

Literature notes: Preclinical literature for this compound is limited; most published work reports clinical endpoints and is outside the scope of this reference list.

The third-party report for this material is published on this page, and every certificate we hold is collected on the certificates of analysis page.

Related Research Compounds

Browse more compounds in GHS, or view the full research peptide catalogue.

• AOD-9604 5mg
• CJC-1295 (NO DAC) 5mg
• IPAMORELIN 10mg
• SERMORELIN 10mg